FPT Digital Retail Joint Stock Company (FRT) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
3 Nov, 2026Executive summary
Q1 2025 net revenue was VND 11.67tn versus VND 9.04tn in Q1 2024; net profit was VND 212.8bn versus VND 60.7bn.
Operating cash flow remained positive at VND 1.14tn; quarter-end cash and cash equivalents were VND 3.39tn.
Financial highlights
Gross revenue was VND 11.70tn versus VND 9.07tn; net revenue after returns was VND 11.67tn versus VND 9.04tn.
Gross profit was VND 2.32tn versus VND 1.81tn; operating profit was VND 267.1bn versus VND 89.1bn.
Profit before tax was VND 272.5bn versus VND 88.7bn; net profit after tax was VND 212.8bn versus VND 60.7bn.
Parent-attributable net profit was VND 168.0bn versus VND 38.8bn; non-controlling interests’ profit was VND 44.8bn versus VND 21.9bn.
Segment performance
Pharmaceutical business revenue was VND 8.05tn versus VND 5.53tn; informatics equipment, phones, components and accessories revenue was VND 3.68tn versus VND 3.58tn.
Segment EBITDA, as presented before interest, tax, depreciation and amortisation, was VND 410.5bn for pharmaceuticals and VND 40.0bn for informatics in Q1 2025.
Other-segment revenue was VND 7.1bn; consolidation eliminations were VND 73.1bn, resulting in total segment revenue of VND 11.67tn.
Latest events from FPT Digital Retail Joint Stock Company
- Parent-attributable loss and negative operating cash flow marked a weak Q1 despite VND 7.753tn revenue.FRT
Q1 2023 - Revenue grew, but H1 swung to operating and net losses.FRT
Q2 2023 - Revenue grew, but 9M 2023 ended in a VND 225.704bn net loss.FRT
Q3 2023 - Revenue increased, but FY2023 ended with a VND 329.2bn net loss and heavy operating cash outflow.FRT
Q4 2023 - Gross profit and operating cash flow improved as revenue fell and losses narrowed.FRT
Q1 2024 - 9M revenue rose and earnings returned to profit, with operating cash flow at VND 1.74T.FRT
Q3 2024 - H1 revenue advanced, earnings returned to profit, and operating cash flow strengthened.FRT
Q2 2024 - FY2024 returned to profit despite lower revenue, with year-end cash rising to VND 1.170tn.FRT
Q4 2024 - H1 profit more than tripled as revenue advanced and pharmaceutical operations led segment results.FRT
Q2 2025